GERN presenting..Oncology Business Development Panel Featured at Anti-Cancer Drug Discovery Confe
/FROM PR NEWSWIRE NEW YORK 800-776-8090/
TO BUSINESS AND MEDICAL EDITORS:
Oncology Business Development Panel Featured at Anti-Cancer Drug Discovery
Conference in Princeton, NJ, June 17-19, 2002.
PRINCETON, N.J., April 25 /PRNewswire/ -- Over twenty-five leading
pharmaceutical and biotech companies will present the latest developments at
the discovery, preclinical, and clinical stages in the field of oncology at
the annual "Anti-Cancer Drug Discovery & Development Summit," in Princeton, NJ
on June 17-19, announces Strategic Research Institute.
"The Oncology Licensing & Deal-making Climate for 2002-03" panel
discussion will feature major pharmaceutical and biotech companies discussing
what types of deals will be in the cards for the near future. Panelists
include: OSI Pharmaceuticals, Amgen, Bristol-Myers Squibb, Roche, Pfizer, and
Genentech. The panel will be moderated by a representative from Defined
Health.
This year's meeting will feature presentations on protein kinases,
ubiquitin ligases, and epothilones, some of the more promising emerging
therapies currently being tested in the clinic. Other topics include
anti-mitotic agents, COX-2, proteasome inhibition, thalidomide, telomerase
inhibition, vascular targeting, and novel taxanes.
Full roster of presenting companies includes Aventis, Pharmacia, Novartis,
Bayer, Bristol-Myers Squibb, Abbott Laboratories, Abgenix, Eli Lilly & Co.,
OSI Pharmaceuticals, Millennium Pharmaceuticals, Pfizer, Celgene, Geron,
Immunex, Keryx Biopharmaceuticals, Signal Research Division of Celgene,
National Cancer Institute, Oxigene, Cyclacel, Rigel, Ribozyme Pharmaceuticals,
Cell Therapeutics, Kosan Biosciences, and ILEX Oncology.
To receive the full agenda, and/or register for the conference, please
contact Jon E. Liong of Strategic Research Institute at jliong@srinstitute.com
or 212-967-0095, x243 (please include name, corporate affiliation, mailing
address, and fax number). LAST DAY TO REGISTER AT THE EARLY BIRD RATE IS
FRIDAY, APRIL 26, 2002.
For more information on exposition, or to register as a sponsor please
contact Mark Alexay at malexay@srinstitute.com.
MAKE YOUR OPINION COUNT - Click Here
tbutton.prnewswire.com
SOURCE Strategic Research Institute
/CONTACT: Jon E. Liong, Producer, Pharmaceutical Division of StrategicResearch
Institute, +1-212-967-0095, ext. 243, jliong@srinstitute.com/
/Web site: srinstitute.com
Apr-25-2002 13:05 GMT
Source PRN PR NewsWire
Categories:
NWR/NJ NWI/MTC MST/R/US/NJ MST/I/DRG |
